{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:43:17Z","timestamp":1781908997036,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1208\/s12248-021-00612-x","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T20:02:16Z","timestamp":1623960136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Population Model of Serum Creatinine as Time-Dependent Covariate in Neonates"],"prefix":"10.1208","volume":"23","author":[{"given":"Wojciech","family":"Krzyzanski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Van Den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Allegaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,17]]},"reference":[{"key":"612_CR1","unstructured":"Food and Drug Administration. General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry. 2019. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/general-clinical-pharmacology-considerations-neonatal-studies-drugs-and-biological-products-guidance Accessed December 2020."},{"key":"612_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/pr.2016.221","volume":"81","author":"RM Ward","year":"2017","unstructured":"Ward RM, Benjamin D, Barrett JS, Allegaert K, Portman R, Davis JM, et al. Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates. Pediatr Res. 2017;81:692\u2013711. https:\/\/doi.org\/10.1038\/pr.2016.221.","journal-title":"Pediatr Res"},{"key":"612_CR3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.4.e49","volume":"103","author":"JP Guignard","year":"1999","unstructured":"Guignard JP, Drukker A. Why do newborn infants have a high plasma creatinine? Pediatrics. 1999;103:e49.","journal-title":"Pediatrics."},{"key":"612_CR4","doi-asserted-by":"publisher","first-page":"F149","DOI":"10.1152\/ajprenal.00439.2013","volume":"307","author":"L Gubhaju","year":"2014","unstructured":"Gubhaju L, Sutherland MR, Horne RS, Medhurst A, Kent AL, Ramsden A, et al. Assessment of renal functional maturation and injury in preterm neonates during the first month of life. Am J Physiol Renal Physiol. 2014;307:F149\u201358. https:\/\/doi.org\/10.1152\/ajprenal.00439.2013.","journal-title":"Am J Physiol Renal Physiol."},{"key":"612_CR5","doi-asserted-by":"publisher","first-page":"F221","DOI":"10.1136\/fn.81.3.F221","volume":"81","author":"C Grimsley","year":"1999","unstructured":"Grimsley C, Thomson AH. Pharmacokinetics and dose requirements of vancomycin in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;81:F221\u20137.","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"612_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00431-006-0189-x","volume":"165","author":"BJ Anderson","year":"2006","unstructured":"Anderson BJ, Allegaert K, Holford NH. Population clinical pharmacology of children: modelling covariate effect. Eur J Pediatr. 2006;165:819\u201329. https:\/\/doi.org\/10.1007\/s00431-006-0189-x.","journal-title":"Eur J Pediatr."},{"key":"612_CR7","unstructured":"Nyberg J, Karlsson MO, Jonsson EN. Implicit and efficient handling of missing covariate information using full random effects modelling. PAGE 28 (2019) Abstr 9181. www.page-meeting.org\/?abstract=9181. Accessed Jan 2021."},{"key":"612_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00467-020-04749-3","volume":"36","author":"T van Donge","year":"2021","unstructured":"van Donge T, Allegaert K, Gotta V, Smits A, Levtchenko E, Mekahli D, et al. Characterizing dynamics of serum creatinine and creatinine clearance in extremely low birth weight neonates during the first 6 weeks of life. Pediatric Nephrology. 2021;36:649\u201359. https:\/\/doi.org\/10.1007\/s00467-020-04749-3.","journal-title":"Pediatric Nephrology."},{"key":"612_CR9","volume-title":"Biomarkers in Kidney Disease","author":"K Allegaert","year":"2015","unstructured":"Allegaert K. Creatinine Assays in Early Infancy: How to Aim for a Moving Target. In: Patel VB, Preedy VR, editors. Biomarkers in Kidney Disease. Dordrecht: Springer Science+Business Media; 2015."},{"key":"612_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1515\/CCLM.2011.167","volume":"49","author":"JR Delanghe","year":"2011","unstructured":"Delanghe JR, Cobbaert C, Harmoinen A, Jansen R, Laitinen P, Panteghini M. Focusing on the clinical impact of standardization of creatinine measurements: a report by the EFCC Working Group oncreatinine standardization. Clin Chem Lab Med. 2011;49:977\u201382.","journal-title":"Clin Chem Lab Med."},{"key":"612_CR11","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1515\/cclm-2013-1035","volume":"52","author":"K Allegaert","year":"2014","unstructured":"Allegaert K, Pauwels S, Smits A, Crevecoeur K, van den Anker J, Mekahli D, et al. Enzymatic isotope dilution mass spectrometry (IDMS) traceable serum creatinine is preferable over Jaffe in neonates and young infants. Clin Chem Lab Med. 2014;52:e107\u20139.","journal-title":"Clin Chem Lab Med."},{"key":"612_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1080\/00365513.2018.1501090","volume":"78","author":"EJ Erlandsen","year":"2018","unstructured":"Erlandsen EJ, Randers E. Challenges in the measurement of plasma creatinine on the Roche cobas c702. Scand J Clin Lab Invest. 2018;78:490\u20135. https:\/\/doi.org\/10.1080\/00365513.2018.1501090.","journal-title":"Scand J Clin Lab Invest."},{"key":"612_CR13","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1208\/s12248-012-9437-3","volume":"15","author":"MA Felmlee","year":"2012","unstructured":"Felmlee MA, Dave RA, Morris ME. Mechanistic models describing active renal reabsorption and secretion: a simulation-based study. AAPS J. 2012;15:278\u201387. https:\/\/doi.org\/10.1208\/s12248-012-9437-3.","journal-title":"AAPS J."},{"key":"612_CR14","volume-title":"Pharmacokinetic and pharmacodynamic data analysis: concepts and applications","author":"J Gabrielsson","year":"2007","unstructured":"Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. 4th ed. Stockholm: Swedish Pharmaceutical Society; 2007.","edition":"4"},{"key":"612_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3389\/fphys.2016.00590","volume":"7","author":"DLI Janzen","year":"2016","unstructured":"Janzen DLI, Bergenholm L, Jirstrand M, Parkinson J, Yates J, Evans ND, et al. Parameter identifiability of fundamental pharmacodynamic models. Front. Physiol. 2016;7:590. https:\/\/doi.org\/10.3389\/fphys.2016.00590.","journal-title":"Front. Physiol."},{"key":"612_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9485-1","volume-title":"Pharmacokinetic-pharmacodynamic modeling and simulation","author":"PL Bonate","year":"2011","unstructured":"Bonate PL. Pharmacokinetic-pharmacodynamic modeling and simulation. 2nd ed. New York: Springer Science; 2011.","edition":"2"},{"key":"612_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1011555016423","volume":"28","author":"Y Yano","year":"2001","unstructured":"Yano Y, Beal SL, Sheiner LB. Evaluating pharmacokinetic\/pharmacodynamic models using the posterior predictive check. J Pharmacokinet Pharmacodyn. 2001;28:171\u201392.","journal-title":"J Pharmacokinet Pharmacodyn."},{"key":"612_CR18","unstructured":"The R Project for Statistical Computing. https:\/\/www.r-project.org\/. Accessed 28 June 2020."},{"issue":"3","key":"612_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1373\/clinchem.2007.099648","volume":"54","author":"F Ceriotti","year":"2008","unstructured":"Ceriotti F, Boyd JC, Klein G, Henny J, Queralto J, Kairisto V, et al. Reference intervals for serum creatinine concentrations: assessment of available data for global application. Clinical Chemistry. 2008;54(3):559\u201366.","journal-title":"Clinical Chemistry"},{"key":"612_CR20","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s00467-010-1533-y","volume":"25","author":"DP Boer","year":"2010","unstructured":"Boer DP, de Rijke YB, Hop WC, Cransberg K, Dorresteijn EM. Reference values for serum creatinine in children younger than 1 year of age. Pediatr Nephrol. 2010;25:2107\u201313. https:\/\/doi.org\/10.1007\/s00467-010-1533-y.","journal-title":"Pediatr Nephrol."},{"key":"612_CR21","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/00002480-197201000-00067","volume":"18","author":"PC Farrell","year":"1972","unstructured":"Farrell PC, Grib NL, Fry DL, Popovich RP, Broviac JW, Babb AL. A comparison of in vitro and in vivo solute-protein binding interactions in normal and uremic subjects. Trans Amer Soc Artf Int Organs. 1972;18:268\u201381.","journal-title":"Trans Amer Soc Artf Int Organs."},{"key":"612_CR22","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0022-3476(86)80245-1","volume":"109","author":"LP Brion","year":"1986","unstructured":"Brion LP, Fleischman AR, McCarton C, Schwartz GJ. A simple estimate of glomerular filtration rate in low birth weight infants during the first year of life: noninvasive assessment of body composition and growth. J Pediatr. 1986;109:698\u2013707.","journal-title":"J Pediatr."},{"key":"612_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196721","volume":"13","author":"H Go","year":"2018","unstructured":"Go H, Momoi N, Kashiwabara N, Haneda K, Chishiki M, Imamura T, et al. Neonatal and maternal serum creatinine levels during the early postnatal period in preterm and term infants. PLoS ONE. 2018;13:e0196721. https:\/\/doi.org\/10.1371\/journal.pone.0196721.","journal-title":"PLoS ONE."},{"key":"612_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/000456329002700201","volume":"27","author":"DJ Savory","year":"1990","unstructured":"Savory DJ. Reference ranges for serum creatinine in infants, children and adolescents. Ann Clin Biochem. 1990;27:99\u2013101.","journal-title":"Ann Clin Biochem."},{"key":"612_CR25","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1208\/s12248-013-9526-y","volume":"15","author":"AM Johansson","year":"2013","unstructured":"Johansson AM, Karlsson MO. Comparison of methods for handling missing covariate data. AAPS J. 2013;15:1232\u201341.","journal-title":"AAPS J."},{"key":"612_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1208\/s12248-019-0331-0","volume":"21","author":"W Krzyzanski","year":"2019","unstructured":"Krzyzanski W, Cook SF, Wilbaux M, Sherwin CMT, Allegaert K, Vermeulen A, et al. Population pharmacokinetic modeling in the presence of missing time-dependent covariates: Impact of body weight on pharmacokinetics of paracetamol in neonates. AAPS J. 2019;21:68. https:\/\/doi.org\/10.1208\/s12248-019-0331-0.","journal-title":"AAPS J."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-021-00612-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-021-00612-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-021-00612-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T15:20:02Z","timestamp":1629300002000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-021-00612-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,17]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["612"],"URL":"https:\/\/doi.org\/10.1208\/s12248-021-00612-x","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,17]]},"assertion":[{"value":"11 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"86"}}